EFDID: 84935EFD: View Filing

Issuer: Avalanche Biotechnologies, Inc. (0001501756) - D

Accession: 0001501756-13-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001501756
  • Entity Name:
    Avalanche Biotechnologies, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    665 Third Street, Suite 250
    San Francisco, CA 94107
  • Persons:
    Related Persons 3
    Thomas W. Chalberg
    Executive OfficerDirector
    Mark S. Blumenkranz
    Director
    Steven D. Schwarz
    Director
EDGAR: Offering Information
  • Accession Date:
    11/26/2013
  • First Sale Date:
    09/07/2010
  • Offering Amount:
    $6,138,277
  • Amount Sold:
    $5,653,890
  • Amount Remaining:
    $484,387
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Avalanche Biotechnologies, Inc./s/ Thomas W. ChalbergThomas W. Chalberg, Ph.D.President & Chief Executive Officer2013-11-22